These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34557982)

  • 1. Prediction of tissue origin of adenocarcinomas in the esophagogastric junction by DNA methylation.
    Zhang CD; Takeshima H; Sekine S; Yamashita S; Liu YY; Hattori N; Abe H; Yamashita H; Fukuda M; Imamura Y; Ushiku T; Katai H; Makino H; Watanabe M; Seto Y; Ushijima T
    Gastric Cancer; 2022 Mar; 25(2):336-345. PubMed ID: 34557982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma.
    Matsuno K; Ishihara R; Ohmori M; Iwagami H; Shichijyo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T; Morishima T; Miyashiro I
    J Gastroenterol; 2019 Sep; 54(9):784-791. PubMed ID: 30927083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma of the stomach and esophagogastric junction with low DNA methylation show poor prognoses.
    Urabe M; Matsusaka K; Ushiku T; Fukuyo M; Rahmutulla B; Yamashita H; Seto Y; Fukayama M; Kaneda A
    Gastric Cancer; 2023 Jan; 26(1):95-107. PubMed ID: 36224483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations.
    Groen-van Schooten TS; Harrasser M; Seidel J; Bos EN; Fleitas T; van Mourik M; Pouw RE; Goedegebuure RSA; Doeve BH; Sanders J; Bos J; van Berge Henegouwen MI; Thijssen VLJL; van Grieken NCT; van Laarhoven HWM; de Gruijl TD; Derks S
    Front Immunol; 2024; 15():1372272. PubMed ID: 38638445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China.
    Wang LD; Zheng S; Zheng ZY; Casson AG
    World J Gastroenterol; 2003 Jun; 9(6):1156-64. PubMed ID: 12800215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma.
    Xu E; Gu J; Hawk ET; Wang KK; Lai M; Huang M; Ajani J; Wu X
    Carcinogenesis; 2013 Dec; 34(12):2750-6. PubMed ID: 23996928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.
    Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction.
    Pera M
    Recent Results Cancer Res; 2000; 155():1-14. PubMed ID: 10693234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considering the esophagogastric junction as a 'zone'.
    Ichihara S; Uedo N; Gotoda T
    Dig Endosc; 2017 Apr; 29 Suppl 2():3-10. PubMed ID: 28425656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas.
    Ferrer-Torres D; Nancarrow DJ; Kuick R; Thomas DG; Nadal E; Lin J; Chang AC; Reddy RM; Orringer MB; Taylor JM; Wang TD; Beer DG
    Oncotarget; 2016 Aug; 7(34):54867-54882. PubMed ID: 27363029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.
    Schildhaus HU; Kröckel I; Lippert H; Malfertheiner P; Roessner A; Schneider-Stock R
    Int J Oncol; 2005 Jun; 26(6):1493-500. PubMed ID: 15870861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic subgroups of esophageal and gastric adenocarcinoma with differential GATA5 DNA methylation associated with clinical and lifestyle factors.
    Wang X; Kang GH; Campan M; Weisenberger DJ; Long TI; Cozen W; Bernstein L; Wu AH; Siegmund KD; Shibata D; Laird PW
    PLoS One; 2011; 6(10):e25985. PubMed ID: 22028801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas.
    Peng D; Hu TL; Jiang A; Washington MK; Moskaluk CA; Schneider-Stock R; El-Rifai W
    PLoS One; 2011; 6(7):e22009. PubMed ID: 21818286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endoscopic therapy for cancer of the esophagogastric junction].
    Fujisaki J; Omae M; Shimizu T; Morishige K; Miyamoto Y; Taniguchi C; Horiuchi Y; Yoshio T; Ishiyama A; Hirasawa T; Yamamoto Y; Tsuchida T; Igarashi M
    Nihon Geka Gakkai Zasshi; 2015 Jan; 116(1):29-34. PubMed ID: 25842810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma of the lower esophagus and the esophagogastric junction.
    Potet F; Fléjou JF; Gervaz H; Paraf F
    Semin Diagn Pathol; 1991 Aug; 8(3):126-36. PubMed ID: 1925120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different histological status of gastritis in superficial adenocarcinoma of the esophagogastric junction.
    Yamada M; Kushima R; Oda I; Mojtahed K; Nonaka S; Suzuki H; Yoshinaga S; Matsubara A; Taniguchi H; Sekine S; Saito Y; Shimoda T
    Jpn J Clin Oncol; 2014 Jan; 44(1):65-71. PubMed ID: 24220802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin phenotypic expression and background mucosa of esophagogastric junctional adenocarcinoma.
    Tsuji N; Ishiguro S; Tsukamoto Y; Mano M; Kasugai T; Miyashiro I; Doki Y; Iishi H; Kudo M
    Gastric Cancer; 2004; 7(2):97-103. PubMed ID: 15224196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus.
    Cameron AJ; Lomboy CT; Pera M; Carpenter HA
    Gastroenterology; 1995 Nov; 109(5):1541-6. PubMed ID: 7557137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma of the esophagogastric junction.
    Jenkins TD; Friedman LS
    Dig Dis; 1999; 17(3):153-62. PubMed ID: 10697664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.